Intellectual Property Lawyers in China
- City
- Beijing · 17
- Shanghai · 10
- Chengdu · 1
- Guangzhou · 1
- Nanjing · 1
- Sanya · 1
- Shenzhen · 1
- Corridor
- Germany · 2
- United Kingdom · 2
- Africa · 1
- Australia · 1
- Canada · 1
- Europe · 1
- Hong Kong · 1
- India · 1
- Japan · 1
- Latin America · 1
- Admitted in
- California · 1
- New York · 1
By firm
Lawyers
| Name | Firm | Ranking | Admitted in | Languages | Corridors |
|---|---|---|---|---|---|
| Han KunBeijing | Eminent PractitionerChambers | New York | — | — | |
| Han KunBeijing | Eminent PractitionerChambers | — | — | — | |
| JunHePartner · Beijing | Band 4Chambers | — | — | — | |
| GLOShanghai | Band 3Chambers | — | — | — | |
| GLOBeijing | Band 3Chambers | California | — | — | |
| KWMManaging Partner of Regulatory & Compliance · Sanya / Beijing | Eminent PractitionerChambers | — | — | — | |
| JT&NSenior Partner · Beijing | Band 4Chambers | — | — | United Kingdom | |
| KWMPartner · Beijing | Eminent PractitionerChambers | — | — | — | |
| JT&NSenior Partner · Shenzhen | — | — | — | — | |
| KWMPartner · Beijing | — | — | French | — | |
| Han KunBeijing | — | — | German | — | |
| Han KunShanghai | — | — | Korean | — | |
| KWMPartner · Chengdu / Beijing | — | — | Japanese, Korean | — | |
| Han KunShanghai | — | — | German | — | |
| JunHePartner · Shanghai | — | — | German | — | |
| Han KunBeijing / Shanghai | — | — | — | — | |
| KWMPartner · Nanjing / Beijing | — | — | German | — | |
| KWMPartner · Shanghai | — | — | French | — | |
| KWMBeijing | — | — | German | — | |
| KWMPartner · Beijing | — | — | — | — | |
| JT&NSenior Partner · Beijing | — | — | — | Germany, Hong Kong | |
| Han KunBeijing | — | — | French | — | |
| GLOShanghai | — | — | French | — | |
| JT&NPartner · Guangzhou | — | — | — | United States, United Kingdom, Australia +13 | |
| Han KunShanghai | — | — | German | — | |
| JunHeCounsel · Beijing | — | — | French | — | |
| Han KunShanghai | — | — | German | — | |
| Han KunShanghai | — | — | German | — |
Related articles
All articles- Review of Cross-Border BD Transactions in China's Innovative Drugs in the First Half of 2026 and Legal Observations: Expansion of Transaction Subject Matter and Evolution of Cooperation Models
- "Use" Defines "Value": Major Changes to the Well-Known Trademark System in the New Trademark Law and Their Implications for Trademark Rights Protection
- Analysis of Patent Legal Issues in AI-Empowered Innovative Drug R&D
- Can Public Internet Data Be Used Directly for AI Training? — Corporate Compliance Boundaries from the EU AI Act to China's Generative AI Regulation